| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |